-
公开(公告)号:WO2007099548A3
公开(公告)日:2007-09-07
申请号:PCT/IN2007/000039
申请日:2007-01-29
申请人: SUN PHARMACEUTICAL INDUSTRIES LIMITED , PATEL, Jiten Ranchhodbhai , PATEL, Gopalkumar Chimanlal , SHETH, Gaurav Sanjivkumar , SHAH, Samir Rameshchandra , MANDHANE, Sanjay Nandlal , CHITTURI, Trinadha Rao , THENNATI, Rajamannar
发明人: PATEL, Jiten Ranchhodbhai , PATEL, Gopalkumar Chimanlal , SHETH, Gaurav Sanjivkumar , SHAH, Samir Rameshchandra , MANDHANE, Sanjay Nandlal , CHITTURI, Trinadha Rao , THENNATI, Rajamannar
摘要: 11 β-hydroxyandrosta-4-ene-3-one, compound of formula (I), and physiologically acceptable salt thereof; wherein R 4 represents moiety selected from a group consisting of (A), (B) and (C), with a proviso that when R 4 represents moiety (C), Z is S.
-
公开(公告)号:WO2013093931A2
公开(公告)日:2013-06-27
申请号:PCT/IN2012/000590
申请日:2012-09-06
申请人: SUN PHARMA ADVANCED RESEARCH COMPANY LTD. , PATEL, Jiten Ranchhodbhai , PATEL, Gopalkumar Chimanlal , SHETH, Gaurav Sanjivkumar , MANDHANE, Sanjay Nandlalji , CHITTURI, Trinadha Rao , THENNATI, Rajamannar
发明人: PATEL, Jiten Ranchhodbhai , PATEL, Gopalkumar Chimanlal , SHETH, Gaurav Sanjivkumar , MANDHANE, Sanjay Nandlalji , CHITTURI, Trinadha Rao , THENNATI, Rajamannar
CPC分类号: C07D489/04 , C07D295/32 , C07D491/22
摘要: The present invention relates to novel hydrazide group containing carbamate prodrugs of phenolic drugs of formula (I) or pharmaceutically acceptable salt thereof, and process for the preparation thereof.
摘要翻译: 本发明涉及式(I)的酚类药物或其药学上可接受的盐的新的含酰肼基团的氨基甲酸酯前体药物及其制备方法。 p>
-
公开(公告)号:WO2013093931A3
公开(公告)日:2013-08-08
申请号:PCT/IN2012000590
申请日:2012-09-06
申请人: SUN PHARMA ADVANCED RES CO LTD , PATEL JITEN RANCHHODBHAI , PATEL GOPALKUMAR CHIMANLAL , SHETH GAURAV SANJIVKUMAR , MANDHANE SANJAY NANDLALJI , CHITTURI TRINADHA RAO , THENNATI RAJAMANNAR
发明人: PATEL JITEN RANCHHODBHAI , PATEL GOPALKUMAR CHIMANLAL , SHETH GAURAV SANJIVKUMAR , MANDHANE SANJAY NANDLALJI , CHITTURI TRINADHA RAO , THENNATI RAJAMANNAR
IPC分类号: C07D489/04 , A61K31/4745 , A61K31/485 , A61K31/55 , A61P23/00 , C07D295/32 , C07D491/22
CPC分类号: C07D489/04 , C07D295/32 , C07D491/22
摘要: The present invention relates to novel hydrazide group containing carbamate prodrugs of phenolic drugs of formula (I) or pharmaceutically acceptable salt thereof, and process for the preparation thereof.
摘要翻译: 本发明涉及含有式(I)的酚类药物或其药学上可接受的盐的氨基甲酸酯前药的新酰肼基团及其制备方法。
-
公开(公告)号:WO2010079499A2
公开(公告)日:2010-07-15
申请号:PCT/IN2009/000112
申请日:2009-02-12
申请人: SUN PHARMA ADVANCED RESEARCH COMPANY LTD., , PATEL, Jiten Ranchhodbhai , PATEL, GopalKumar Chimanlal , SHETH, Gaurav Sanjivkumar , CHITTURI, Trinadha Rao , THENNATI, Rajamannar
发明人: PATEL, Jiten Ranchhodbhai , PATEL, GopalKumar Chimanlal , SHETH, Gaurav Sanjivkumar , CHITTURI, Trinadha Rao , THENNATI, Rajamannar
IPC分类号: C07D305/14
CPC分类号: C07D305/14
摘要: The present invention relates to compounds of formula I or salts thereof, wherein, R 1 is selected from the group consisting of hydrogen and R 4 ; R 2 is selected from the group consisting of hydrogen, acetyl and R 4 ; R 3 is selected from the group consisting of alkyl, -O-alkyl,-NH-alkyl, aryl and heterocyclyl; R 4 represents a moiety (A) wherein, X is selected from the group consisting of a single bond, alkylene, alkenylene, alkynylene, arylene or a heterocyclylene moiety; R 5 and R 6 are same or different and are independently selected from hydrogen, alkyl, aryl or heterocyclyl; or R 5 and R 6 may form together with the nitrogen atom to which they are attached a heterocyclyl ring system.
摘要翻译: 本发明涉及式I化合物或其盐,其中R 1选自氢和R 4; R2选自氢,乙酰基和R4; R 3选自烷基,-O-烷基,-NH-烷基,芳基和杂环基; R4表示部分(A),其中X选自单键,亚烷基,亚烯基,亚炔基,亚芳基或亚杂环基; R5和R6相同或不同,独立地选自氢,烷基,芳基或杂环基; 或者R 5和R 6可以与它们所连接的氮原子一起形成杂环基环系。
-
公开(公告)号:WO2010079499A3
公开(公告)日:2011-09-09
申请号:PCT/IN2009000112
申请日:2009-02-12
申请人: SUN PHARMA ADVANCED RES CO LTD , PATEL JITEN RANCHHODBHAI , PATEL GOPALKUMAR CHIMANLAL , SHETH GAURAV SANJIVKUMAR , CHITTURI TRINADHA RAO , THENNATI RAJAMANNAR
发明人: PATEL JITEN RANCHHODBHAI , PATEL GOPALKUMAR CHIMANLAL , SHETH GAURAV SANJIVKUMAR , CHITTURI TRINADHA RAO , THENNATI RAJAMANNAR
IPC分类号: C07D305/14
CPC分类号: C07D305/14
摘要: The present invention relates to compounds of formula I or salts thereof, wherein, R1 is selected from the group consisting of hydrogen and R4; R2 is selected from the group consisting of hydrogen, acetyl and R4; R3 is selected from the group consisting of alkyl, -O-alkyl,-NH-alkyl, aryl and heterocyclyl; R4 represents a moiety (A) wherein, X is selected from the group consisting of a single bond, alkylene, alkenylene, alkynylene, arylene or a heterocyclylene moiety; R5 and R6 are same or different and are independently selected from hydrogen, alkyl, aryl or heterocyclyl; or R5 and R6 may form together with the nitrogen atom to which they are attached a heterocyclyl ring system.
摘要翻译: 本发明涉及式I化合物或其盐,其中R 1选自氢和R 4; R2选自氢,乙酰基和R4; R 3选自烷基,-O-烷基,-NH-烷基,芳基和杂环基; R4表示部分(A),其中X选自单键,亚烷基,亚烯基,亚炔基,亚芳基或亚杂环基; R5和R6相同或不同,独立地选自氢,烷基,芳基或杂环基; 或者R 5和R 6可以与它们所连接的氮原子一起形成杂环基环系。
-
公开(公告)号:WO2007099548A2
公开(公告)日:2007-09-07
申请号:PCT/IN2007000039
申请日:2007-01-29
申请人: SUN PHARMACEUTICAL IND LTD , PATEL JITEN RANCHHODBHAI , PATEL GOPALKUMAR CHIMANLAL , SHETH GAURAV SANJIVKUMAR , SHAH SAMIR RAMESHCHANDRA , MANDHANE SANJAY NANDLAL , CHITTURI TRINADHA RAO , THENNATI RAJAMANNAR
发明人: PATEL JITEN RANCHHODBHAI , PATEL GOPALKUMAR CHIMANLAL , SHETH GAURAV SANJIVKUMAR , SHAH SAMIR RAMESHCHANDRA , MANDHANE SANJAY NANDLAL , CHITTURI TRINADHA RAO , THENNATI RAJAMANNAR
CPC分类号: C07J31/006 , C07J3/005 , C07J17/00 , C07J41/0038 , C07J71/0015
摘要: 11 ß-hydroxyandrosta-4-ene-3-one, compound of formula (I), and physiologically acceptable salt thereof; wherein R 4 represents moiety selected from a group consisting of (A), (B) and (C), with a proviso that when R 4 represents moiety (C), Z is S.
摘要翻译: 11β-羟基雄甾-4-烯-3-酮,式(I)化合物及其生理学上可接受的盐; 其中R 4表示选自(A),(B)和(C)的部分,条件是当R 4代表(C)部分时, Z是S.
-
-
-
-
-